Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk
Gamma-glutamyltransferase (GGT) is a well-established serum marker for alcohol-related liver disease. However, GGT’s predictive utility applies well beyond liver disease: elevated GGT is linked to increased risk to a multitude of diseases and conditions, including cardiovascular disease, diabetes, m...
Main Authors: | Gerald Koenig, Stephanie Seneff |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2015/818570 |
Similar Items
-
Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk
by: Koenig, Gerald, et al.
Published: (2015) -
Studies on hepatic gamma glutamyltransferase
by: Ding, Jeak Ling
Published: (1982) -
Gamma - Glutamyltransferases of Human Liver and Kidney
by: Guma, L. A.
Published: (1978) -
Gamma-glutamyltransferase, possible novel biomarker in colon diverticulosis: a case-control study
by: Constantin Bălăeţ, et al.
Published: (2018-01-01) -
Serum Gamma-Glutamyltransferase Levels Predict Clinical Outcomes in Hemodialysis Patients.
by: Woo Yeong Park, et al.
Published: (2015-01-01)